의료 공급망 관리 시장 예측(-2034년) : 구성 요소, 기능, 기술, 제공 모델, 용도, 최종사용자 및 지역별 세계 분석

According to Stratistics MRC, the Global Healthcare Supply Chain Management Market is accounted for $6.2 billion in 2026 and is expected to reach $14.8 billion by 2034, growing at a CAGR of 11.4% during the forecast period. Healthcare Supply Chain Management (HSCM) encompasses the end-to-end coordination of procurement, inventory, logistics, and distribution of pharmaceutical products, medical devices, and clinical supplies across the healthcare ecosystem. It integrates advanced software platforms with real-time data analytics to ensure uninterrupted product flow from manufacturers to patients, reducing waste, minimizing stockouts, and maintaining compliance with regulatory mandates.

Market Dynamics:

Driver:

Rising demand for operational efficiency and cost containment in healthcare delivery

Healthcare organizations are under mounting financial pressure to curtail operational expenditures without compromising patient outcomes. Supply chain management solutions enable institutions to optimize procurement cycles, reduce excess inventory, and automate manual workflows. By deploying advanced analytics and AI-driven forecasting, hospitals and distributors can anticipate demand fluctuations, prevent drug shortages, and lower carrying costs. This transition from reactive to proactive supply chain strategies is accelerating adoption, particularly among large health systems seeking to eliminate systemic inefficiencies across geographically dispersed facilities.

Restraint:

Fragmented IT infrastructure and interoperability challenges

A significant barrier to widespread adoption is the lack of standardized data formats and seamless integration across disparate hospital information systems, ERP platforms, and supplier networks. Many healthcare institutions operate legacy systems that are incompatible with modern HSCM solutions, requiring costly and time-intensive upgrades. Additionally, variations in regulatory frameworks across jurisdictions complicate cross-border supply chain visibility. These interoperability gaps hinder real-time data sharing, limit end-to-end traceability, and increase the risk of medication errors, ultimately slowing the pace of digital supply chain transformation.

Opportunity:

Expansion of AI-driven demand forecasting and blockchain-enabled traceability

The convergence of artificial intelligence and blockchain technology presents a transformative opportunity for healthcare supply chains. AI-powered predictive models can analyze historical consumption patterns, seasonal disease trends, and procurement data to generate precise demand forecasts, minimizing both overstock and shortages. Simultaneously, blockchain platforms offer immutable transaction records that enhance product traceability from manufacturer to patient, combating counterfeit drugs and ensuring cold-chain compliance. As regulatory bodies mandate greater drug supply transparency, vendors offering integrated AI-blockchain supply chain solutions stand to capture substantial market share.

Threat:

Geopolitical disruptions and single-source supplier dependency

Global healthcare supply chains remain acutely vulnerable to geopolitical instability, trade restrictions, and concentrated supplier dependencies, particularly for active pharmaceutical ingredients sourced from a limited number of countries. Disruptions arising from export bans, port congestion, or raw material shortages can cascade rapidly through supply networks, leading to critical drug shortages and patient care delays. The COVID-19 pandemic exposed these structural vulnerabilities, prompting health systems and governments to reassess supply chain resilience. However, diversifying supplier bases and building regional stockpiles entail substantial investment and operational complexity.

Covid-19 Impact:

The COVID-19 pandemic profoundly disrupted healthcare supply chains, exposing critical gaps in inventory visibility, demand forecasting, and supplier diversification. Unprecedented surges in demand for PPE, ventilators, and vaccines overwhelmed existing distribution networks, triggering widespread shortages. In response, health systems accelerated digital transformation initiatives, deploying real-time tracking platforms and AI-driven forecasting tools to navigate supply volatility. The crisis catalyzed long-term investment in supply chain resilience and advanced analytics, positioning the market for robust post-pandemic growth as institutions prioritize operational agility and end-to-end traceability.

The software segment is expected to be the largest during the forecast period

The software segment is expected to account for the largest market share during the forecast period, driven by widespread adoption of inventory management platforms, ERP-integrated procurement solutions, and demand forecasting tools. Healthcare organizations rely heavily on software to digitize manual workflows, ensure regulatory compliance, and achieve real-time visibility across multi-tiered supply networks. The growing preference for cloud-based deployment has further expanded the software segment, enabling rapid scalability and cost-effective access across hospitals of varying sizes.

The procurement management segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the procurement management segment is predicted to witness the highest growth rate, driven by the increasing need to reduce operational costs, improve inventory visibility, and ensure timely availability of medical supplies. Healthcare organizations are adopting digital procurement platforms, automation, and data analytics to streamline purchasing processes and enhance supplier collaboration. Additionally, the growing focus on value-based healthcare and minimizing supply disruptions is accelerating procurement management adoption across healthcare facilities.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by a mature healthcare infrastructure, high technology adoption rates, and a stringent regulatory environment demanding supply chain transparency. The United States, in particular, benefits from early adoption of ERP and WMS platforms among large hospital networks, alongside ongoing compliance obligations under the DSCSA. The presence of leading software vendors and well-capitalized healthcare distributors such as McKesson and Cardinal Health further reinforces the region's market dominance.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by rapid healthcare infrastructure expansion, rising pharmaceutical manufacturing activity, and growing government initiatives to modernize hospital supply chains. Countries such as China, India, and South Korea are investing heavily in digital health platforms and cold-chain logistics to support their burgeoning pharmaceutical export industries and large domestic patient populations. The proliferation of low-cost cloud-based solutions is also enabling smaller healthcare providers in the region to adopt HSCM tools at scale.

Key players in the market

Some of the key players in Healthcare Supply Chain Management Market include SAP SE, Oracle Corporation, McKesson Corporation, Cardinal Health, Inc., Cencora, Inc., Global Healthcare Exchange (GHX), Infor Inc., Tecsys Inc., Manhattan Associates, Inc., Blue Yonder Group, Inc., Kinaxis Inc., Epicor Software Corporation, Avery Dennison Corporation, Medline Industries, LP, Premier, Inc.

Key Developments:

In March 2026, McKesson Corporation announced the expansion of its CoverMyMeds platform to include AI-driven prior authorization automation capabilities, enabling healthcare providers to expedite medication access for patients and reduce administrative burden across pharmacy benefit networks.

In February 2026, SAP SE unveiled an enhanced version of its SAP Intelligent Asset Management solution integrated with generative AI capabilities, enabling pharmaceutical companies to predict equipment failures and optimize maintenance schedules within their manufacturing and supply chain operations.

Components Covered:

• Software
• Services

Functions Covered:

• Procurement Management
• Inventory Management
• Order Management
• Warehouse Management
• Logistics & Distribution Management
• Demand Planning & Forecasting
• Asset Management
• Returns & Recall Management

Technologies Covered:

• Artificial Intelligence (AI)
• Machine Learning (ML)
• Internet of Things (IoT)
• Blockchain
• RFID & Barcode Technology
• Big Data Analytics
• Cloud Computing
• Robotic Process Automation (RPA)

Delivery Models Covered:

• In-house Management
• Outsourced Supply Chain Management
• Third-Party Logistics (3PL)

Applications Covered:

• Drug Supply Chain Management
• Medical Device Supply Chain Management
• Vaccine Supply Chain Management
• Surgical Supplies Management
• Laboratory Supply Management
• Cold Chain Management
• Patient Consumables Management

End Users Covered:

• Hospitals & Clinics
• Pharmaceutical Companies
• Biotechnology Companies
• Medical Device Manufacturers
• Healthcare Distributors
• Retail & Online Pharmacies
• Diagnostic Laboratories
• Government & Public Health Organizations

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Healthcare Supply Chain Management Market, By Component

• 5.1 Software
  • 5.1.1 Inventory Management Software
  • 5.1.2 Procurement & Sourcing Software
  • 5.1.3 Warehouse Management Software
  • 5.1.4 Transportation & Logistics Management Software
  • 5.1.5 Demand Forecasting & Analytics Software
  • 5.1.6 Supplier Relationship Management Software
  • 5.1.7 Track & Trace Solutions
• 5.2 Services
  • 5.2.1 Consulting Services
  • 5.2.2 Integration & Deployment Services
  • 5.2.3 Support & Maintenance Services
  • 5.2.4 Managed Services

6 Global Healthcare Supply Chain Management Market, By Function

• 6.1 Procurement Management
• 6.2 Inventory Management
• 6.3 Order Management
• 6.4 Warehouse Management
• 6.5 Logistics & Distribution Management
• 6.6 Demand Planning & Forecasting
• 6.7 Asset Management
• 6.8 Returns & Recall Management
• 6.9 Supplier Management

7 Global Healthcare Supply Chain Management Market, By Technology

• 7.1 Artificial Intelligence (AI)
• 7.2 Machine Learning (ML)
• 7.3 Internet of Things (IoT)
• 7.4 Blockchain
• 7.5 RFID & Barcode Technology
• 7.6 Big Data Analytics
• 7.7 Cloud Computing
• 7.8 Robotic Process Automation (RPA)

8 Global Healthcare Supply Chain Management Market, By Delivery Model

• 8.1 In-house Management
• 8.2 Outsourced Supply Chain Management
• 8.3 Third-Party Logistics (3PL)

9 Global Healthcare Supply Chain Management Market, By Application

• 9.1 Drug Supply Chain Management
• 9.2 Medical Device Supply Chain Management
• 9.3 Vaccine Supply Chain Management
• 9.4 Surgical Supplies Management
• 9.5 Laboratory Supply Management
• 9.6 Cold Chain Management
• 9.7 Patient Consumables Management

10 Global Healthcare Supply Chain Management Market, By End User

• 10.1 Hospitals & Clinics
• 10.2 Pharmaceutical Companies
• 10.3 Biotechnology Companies
• 10.4 Medical Device Manufacturers
• 10.5 Healthcare Distributors
• 10.6 Retail & Online Pharmacies
• 10.7 Diagnostic Laboratories
• 10.8 Government & Public Health Organizations

11 Global Healthcare Supply Chain Management Market, By Geography

• 11.1 North America
  • 11.1.1 United States
  • 11.1.2 Canada
  • 11.1.3 Mexico
• 11.2 Europe
  • 11.2.1 United Kingdom
  • 11.2.2 Germany
  • 11.2.3 France
  • 11.2.4 Italy
  • 11.2.5 Spain
  • 11.2.6 Netherlands
  • 11.2.7 Belgium
  • 11.2.8 Sweden
  • 11.2.9 Switzerland
  • 11.2.10 Poland
  • 11.2.11 Rest of Europe
• 11.3 Asia Pacific
  • 11.3.1 China
  • 11.3.2 Japan
  • 11.3.3 India
  • 11.3.4 South Korea
  • 11.3.5 Australia
  • 11.3.6 Indonesia
  • 11.3.7 Thailand
  • 11.3.8 Malaysia
  • 11.3.9 Singapore
  • 11.3.10 Vietnam
  • 11.3.11 Rest of Asia Pacific
• 11.4 South America
  • 11.4.1 Brazil
  • 11.4.2 Argentina
  • 11.4.3 Colombia
  • 11.4.4 Chile
  • 11.4.5 Peru
  • 11.4.6 Rest of South America
• 11.5 Rest of the World (RoW)
  • 11.5.1 Middle East
    • 11.5.1.1 Saudi Arabia
    • 11.5.1.2 United Arab Emirates
    • 11.5.1.3 Qatar
    • 11.5.1.4 Israel
    • 11.5.1.5 Rest of Middle East
  • 11.5.2 Africa
    • 11.5.2.1 South Africa
    • 11.5.2.2 Egypt
    • 11.5.2.3 Morocco
    • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

• 12.1 Industry Value Network and Supply Chain Assessment
• 12.2 White-Space and Opportunity Mapping
• 12.3 Product Evolution and Market Life Cycle Analysis
• 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

• 13.1 Mergers and Acquisitions
• 13.2 Partnerships, Alliances, and Joint Ventures
• 13.3 New Product Launches and Certifications
• 13.4 Capacity Expansion and Investments
• 13.5 Other Strategic Initiatives

14 Company Profiles

• 14.1 SAP SE
• 14.2 Oracle Corporation
• 14.3 McKesson Corporation
• 14.4 Cardinal Health, Inc.
• 14.5 Cencora, Inc.
• 14.6 Global Healthcare Exchange (GHX)
• 14.7 Infor Inc.
• 14.8 Tecsys Inc.
• 14.9 Manhattan Associates, Inc.
• 14.10 Blue Yonder Group, Inc.
• 14.11 Kinaxis Inc.
• 14.12 Epicor Software Corporation
• 14.13 Avery Dennison Corporation
• 14.14 Medline Industries, LP
• 14.15 Premier, Inc.